Evaluation of Point-of-care Tests for the Diagnosis of Cutaneous Leishmaniasis in Afghanistan
Last updated on July 2021Recruitment
- Recruitment Status
- Completed
Summary
- Conditions
- Cutaneous Leishmaniases
- Type
- Observational
- Design
- Observational Model: Case-ControlTime Perspective: Prospective
Participation Requirements
- Age
- Between 2 years and 125 years
- Gender
- Both males and females
Description
The investigators enrolled 274 CL suspects in the study to determine the diagnostic performance of LoopampTM Leishmania Detection Kit and CL DetectTM Rapid Test for CL diagnosis in Afghanistan. The study was conducted at the National Malaria & Leishmaniasis Control Program (NMLCP) Leishmaniasis Clin...
The investigators enrolled 274 CL suspects in the study to determine the diagnostic performance of LoopampTM Leishmania Detection Kit and CL DetectTM Rapid Test for CL diagnosis in Afghanistan. The study was conducted at the National Malaria & Leishmaniasis Control Program (NMLCP) Leishmaniasis Clinic in Kabul, Afghanistan.
Tracking Information
- NCT #
- NCT03435419
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Martijn Vink, MD, MPH HealthNet TPO Study Director: Israel Cruz, PhD Foundation for Innovative New Diagnostics